We are pleased to share the following conversation with Glen Tullman, CEO of Livongo Health (Nasdaq: LVGO). The interview took place in February 2020.

Members, log in below to access the restricted content.

Not a member?

Thank you for your interest.  Please note that MOI Global is closed to new members at this time. If you would like to join the waiting list, complete the following form:


Glen Tullman is the Executive Chairman and Founder of Livongo Health (Nasdaq: LVGO), the consumer first digital health pioneer committed to empowering people with chronic conditions to live better and healthier lives. He is dedicated to finding a cure for diabetes and other chronic conditions—and to keeping people healthy until these cures are found.

A visionary leader and entrepreneur, he previously ran two public companies that changed the way health care is delivered. Prior to Livongo, Tullman served as Chief Executive Officer of Allscripts, which was, during his tenure, the leading provider of electronic health records, practice management, and electronic prescribing systems. He took Allscripts public. Prior to Allscripts, he was Chief Executive Officer of Enterprise Systems, which he also took public and then sold to McKesson/HBOC. He is the author of On Our Terms: Empowering the New Health Consumer, in which he proposes new solutions to address the chronic-condition epidemic facing our country.

A strong proponent of philanthropy, Tullman was honored in 2019 with a Robert F. Kennedy Human Rights Ripple of Hope Award for his career focused on improving the safety, empathy, and efficiency of our healthcare system. He also serves as a Director Emeritus to the International Board of the Juvenile Diabetes Research Foundation and as a Board Member of the American Diabetes Association. Tullman has three amazing children that inspire him every day.